The idea of using stem cells for scleroderma seems a bit more promising today. A new NIH-funded study reported in the New England Journal of Medicine (NEJM) gives some hope for the use of a combination of a specific type of myeloablation and a transplant of hematopoietic stem cells (HSC). This approach yields improved long-term … Stem cells for scleroderma, new NEJM article reports promise Read More »